Parainfluenza Virus Workup
- Author: Subhash Chandra Parija, MBBS, MD, PhD, FRCPath; Chief Editor: Burke A Cunha, MD more...
Laboratory Studies
- The CBC count is usually within the reference range. Lymphocytosis may be present.
- Virus antigen detection and isolation
- Collection and preparation of clinical specimens: Nasopharyngeal aspirations, nasal washings, and nasal aspirations are optimum specimens for collection. Throat swabs and nasal swabs can also be used. Specimens should be collected and placed in viral transport media (VTM), preferably at 4°C; if a delay of more than 24 hours is anticipated, specimens should be frozen. Nonrespiratory specimens such as CSF, rectal swabs, and stool, though rare, can be used. Paired sera (acute and convalescent phase) should be collected, separated quickly, and stored at either -20°C or -70°C; both samples should be tested simultaneously.
- Electron microscopy: Microdrops of secretions or garglings are placed directly on carbon-coated electron microscopy grids and stained with phosphotungstic acid. Virions typical of the Paramyxoviridae may be observed. However, this study yields poor sensitivity.
- Immunofluorescence: Indirect immunofluorescence is normally used with antisera against each serotype of parainfluenza virus. However, immunofluorescence findings cannot be used as the sole diagnostic criterion, as it also yields poor sensitivity. A study carried out in Arizona between 1983 and 1985 showed that immunofluorescence revealed human parainfluenza virus (HPIV)–1 in only 63% of throat specimens from which this serotype was isolated in tissue cultures. HPIV-3 was revealed in only 31% of virus-culture–positive throat secretions.
- Direct detection of viral antigens: HPIV antigen can be detected with enzyme-linked immunoassay (ELISA), radioimmunoassay, fluoroimmunoassay, and immunofluorescence. Synthesized recombinant HPIV-1 and HPIV-3 nucleocapsid proteins in the yeast Saccharomyces cerevisiae are used as a source of antigens.[6] The latter two tests are both rapid and specific. Shell vial assay is another method for rapid identification of HPIV. Shell vials have yielded an average sensitivity of 84% in testing against standard tissue culture–positive HPIV cases.
- Virus isolation: HPIV grows best in primary monkey kidney (PMK) cells (rhesus monkey kidney cells, cynomolgus, and African green monkeys). The LLC-MK2 strain is also excellent for continued passage and is almost as good as PMK cells for primary isolation. HPIV-2 induced host ADAM8 expression in human salivary parotid adenocarcinoma cell line (HSY) during cell fusion. ADAM8 is responsible for cell-to-cell fusion and formation of multinucleate giant cell formation, especially in osteoclast formation.[7] Trypsin (2-3 mg/mL) must be added to the maintenance medium of LLC-MK2 cells to recover all HPIV serotypes. Proteases are necessary for parainfluenza virus to replicate, and it is hypothesized that proteases present in primary cell cultures are absent in continuous cell lines.
- Detection and typing: Cytopathic effects (CPEs) are rarely demonstrated during primary isolation of HPIV in tissue culture except with HPIV-2, which, when cultured, shows syncytia formation. All HPIVs demonstrate greater cytopathic effects upon adaptation to a particular cell line, with HPIV-3 being the most aggressive, destroying more than 50% of tissue culture monolayer by the third day. Virus growth is detected with hemadsorption inhibition using guinea pig erythrocytes within 3-10 days of incubation. However, the prolonged incubation time (3-10 d) required for virus isolation severely restricts the usefulness of virus isolation in short-term management.
- Serologic diagnosis: A 4-fold rise or drop in titer is generally thought to signify acute infection if the testing is performed at the same time on paired acute- and convalescent-phase serum pimples. Hemagglutination inhibition, neutralization, complement fixation, ELISA, radioimmune assays, and Western blotting are frequently used antibody-based serological tests for diagnosis of HPIV infections.
- Genomic detection: HPIV RNA can be detected directly with Northern hybridization or a dot blot analysis using virus-specific DNA probes. Polymerase chain reaction (PCR) assay is sensitive and specific in detecting HPIV. A multiplex reverse-transcriptase PCR (RT-PCR) assay for detecting HPIV-1, HPIV-2, and HPIV-3 has been developed. RT-PCR enzyme hybridization assay (RT-PCR-EHA) is available for detecting HPIV types 1-4, respiratory syncytial viruses A and B, and influenza A and B virus, with a reported sensitivity of 95-100% and specificity of 97-100% when compared with results of tissue culture. PCR yielded twice the sensitivity of cultures and 4 times the sensitivity of fluorescent antibody staining.[8] The RT-PCR-EHA yields results in approximately 7 hours. A multiplex RT-PCR assay kit under dual priming oligonucleotide system (DPO) that is used to detect 12 common viruses causing respiratory tract infections in children has recently become available.[9]
Imaging Studies
- Radiographs of the neck or chest are important if epiglottitis, croup, or pneumonia is a possibility.
- Anteroposterior views of the neck may demonstrate subglottic swelling with narrowing of the air shadow of the trachea (steeple sign) with croup; in patients with epiglottitis, lateral views may demonstrate enlargement of the epiglottis and ballooning of the hypopharynx.
Histologic Findings
The epithelium of the respiratory tract may show inflammation and necrosis. Subglottic tissues in particular may appear to be involved.
Fry AM, Curns AT, Harbour K, et al. Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. Clin Infect Dis. Oct 15 2006;43(8):1016-22. [Medline].
Lau SK, To WK, Tse PW, et al. Human parainfluenza virus 4 outbreak and the role of diagnostic tests. J Clin Microbiol. Sep 2005;43(9):4515-21. [Medline].
Karron RA and Collins PL. Knipe DM; Howley PM; Griffin DE; Martin MA; Lamb RA; Roizman B; Strauss SE. Field's Virology. 5th. Philadelphia: Lippincott Williams & Wilkins; 2007:1497-1527.
Weinberg GA, Hall CB, Iwane MK, Poehling KA, Edwards KM, Griffin MR, et al. Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. J Pediatr. May 2009;154(5):694-9. [Medline].
Johnson D. Croup. Clin Evid (Online). Mar 10 2009;2009:[Medline].
Juozapaitis M, Zvirbliene A, Kucinskaite I, Sezaite I, Slibinskas R, Coiras M, et al. Synthesis of recombinant human parainfluenza virus 1 and 3 nucleocapsid proteins in yeast Saccharomyces cerevisiae. Virus Res. May 2008;133(2):178-86. [Medline].
Ma GF, Miettinen S, Porola P, Hedman K, Salo J, Konttinen YT. Human parainfluenza virus type 2 (HPIV2) induced host ADAM8 expression in human salivary adenocarcinoma cell line (HSY) during cell fusion. BMC Microbiol. 2009;9:55. [Medline].
Kuypers J, Campbell AP, Cent A, Corey L, Boeckh M. Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients. Transpl Infect Dis. Aug 2009;11(4):298-303. [Medline].
Yoo SJ, Kuak EY, Shin BM. Detection of 12 respiratory viruses with two-set multiplex reverse transcriptase-PCR assay using a dual priming oligonucleotide system. Korean J Lab Med. Dec 2007;27(6):420-7. [Medline].
Watanabe M, Mishin VP, Brown SA, Russell CJ, Boyd K, Babu YS, et al. Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice. Antimicrob Agents Chemother. Sep 2009;53(9):3942-51. [Medline].
Gomez M, Mufson MA, Dubovsky F, Knightly C, Zeng W, Losonsky G. Phase-I study medi-534, of a live, attenuated intranasal vaccine against respiratory syncytial virus and parainfluenza-3 virus in seropositive children. Pediatr Infect Dis J. Jul 2009;28(7):655-8. [Medline].
Skiadopoulos MH, Tao T, Surman SR, Collins PL, Murphy BR. Generation of a parainfluenza virus type 1 vaccine candidate by replacing the HN and F glycoproteins of the live-attenuated PIV3 cp45 vaccine virus with their PIV1 counterparts. Vaccine. Oct 14 1999;18(5-6):503-10. [Medline].
Alymova IV, Taylor G, Mishin VP, Watanabe M, Murti KG, Boyd K. Loss of the N-linked glycan at residue 173 of human parainfluenza virus type 1 hemagglutinin-neuraminidase exposes a second receptor-binding site. J Virol. Sep 2008;82(17):8400-10. [Medline].

